Scarica l'app Stockscreener
31.82
1.73%
0.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RARE Giù?
Forum
Previsione
Frazionamento azionario
Ultragenyx Pharmaceutical Inc Borsa (RARE) Ultime notizie
Real time scanner hits for Ultragenyx Pharmaceutical Inc. explained2025 Top Gainers & Consistent Profit Alerts - Newser
Ultragenyx Pharmaceutical Inc. stock daily chart insightsShort Setup & Daily Risk Controlled Trade Plans - Newser
Institutional scanner results for Ultragenyx Pharmaceutical Inc.Market Sentiment Report & Entry Point Confirmation Alerts - Newser
How to use Fibonacci retracement on Ultragenyx Pharmaceutical Inc.Weekly Trend Report & Fast Gain Stock Tips - Newser
Live market analysis of Ultragenyx Pharmaceutical Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
What machine learning models say about Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
What earnings revisions data tells us about Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Is Ultragenyx Pharmaceutical Inc. stock a good pick for beginnersGap Up & Long-Term Growth Plans - خودرو بانک
Ultragenyx Pharmaceutical Inc. recovery potential after sell offWeekly Investment Report & Safe Entry Point Identification - Newser
Applying sector rotation models to Ultragenyx Pharmaceutical Inc.July 2025 Selloffs & Safe Capital Growth Tips - Newser
Real time pattern detection on Ultragenyx Pharmaceutical Inc. stock2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Rare Disease Therapy Approvals By FDA Speed Up Via New ProcessNeurogene (NASDAQ:NGNE) - Benzinga
Ultragenyx’s Strategic Momentum: A Rare Disease Biotech on the Cusp of Multiple Catalysts - AInvest
Ultragenyx's Strategic Momentum in Rare Disease Innovation and Commercialization - AInvest
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 10 - MarketScreener
Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN
News impact scoring models applied to Ultragenyx Pharmaceutical Inc.Weekly Risk Report & Entry Point Confirmation Signals - Newser
Long term hold vs stop loss in Ultragenyx Pharmaceutical Inc.Global Markets & Low Risk High Reward Trade Ideas - Newser
What does recent volatility data suggest for Ultragenyx Pharmaceutical Inc.2025 Key Lessons & High Accuracy Investment Signals - Newser
A | Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک
Reversal indicators forming on Ultragenyx Pharmaceutical Inc. stockGap Up & Weekly Return Optimization Plans - Newser
How to build a dashboard for Ultragenyx Pharmaceutical Inc. stockTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Order flow analysis tools used on Ultragenyx Pharmaceutical Inc.July 2025 Gainers & Consistent Growth Equity Picks - Newser
Intraday pattern recognizer results for Ultragenyx Pharmaceutical Inc.Quarterly Profit Review & Community Consensus Trade Signals - Newser
Ultragenyx Pharmaceutical shares rise 1.43% after-hours following a class action investigation announcement. - AInvest
What indicators show strength in Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Does Ultragenyx Pharmaceutical Inc. offer margin of safetyTreasury Yields & Real-Time Volume Analysis Alerts - خودرو بانک
Trend analysis for Ultragenyx Pharmaceutical Inc. this weekQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
How to interpret RSI for Ultragenyx Pharmaceutical Inc. stockMarket Performance Report & Long-Term Capital Growth Strategies - Newser
How hedge fund analytics apply to Ultragenyx Pharmaceutical Inc. stockShort Setup & Weekly Chart Analysis and Guides - Newser
Will earnings trigger a reversal in Ultragenyx Pharmaceutical Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Top chart patterns to watch in Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - Newser
Quantitative breakdown of Ultragenyx Pharmaceutical Inc. recent moveCEO Change & Entry Point Confirmation Signals - Newser
Ultragenyx Pharmaceutical Inc. stock trend forecastInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Rallies & Weekly Market Pulse Alerts - خودرو بانک
Can Ultragenyx Pharmaceutical Inc. ride the EV waveTrade Exit Summary & AI Optimized Trading Strategy Guides - خودرو بانک
What’s the outlook for Ultragenyx Pharmaceutical Inc.’s sectorPortfolio Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-02 13:45:06 - Newser
Pomerantz LLP Investigates Claims Against Ultragenyx Pharmaceutical Inc. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - FinancialContent
Full technical analysis of Ultragenyx Pharmaceutical Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - Newser
Is Ultragenyx Pharmaceutical Inc. being accumulated by smart moneyCPI Data & Weekly High Momentum Picks - خودرو بانک
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):